193 related articles for article (PubMed ID: 26358398)
41. Breast cancer antiestrogen resistance 3 (BCAR3) promotes cell motility by regulating actin cytoskeletal and adhesion remodeling in invasive breast cancer cells.
Wilson AL; Schrecengost RS; Guerrero MS; Thomas KS; Bouton AH
PLoS One; 2013; 8(6):e65678. PubMed ID: 23762409
[TBL] [Abstract][Full Text] [Related]
42. Overexpressed hPTTG1 promotes breast cancer cell invasion and metastasis by regulating GEF-H1/RhoA signalling.
Liao YC; Ruan JW; Lua I; Li MH; Chen WL; Wang JR; Kao RH; Chen JH
Oncogene; 2012 Jun; 31(25):3086-97. PubMed ID: 22002306
[TBL] [Abstract][Full Text] [Related]
43. Odontogenic ameloblast associated protein as a novel biomarker for human breast cancer.
Siddiqui S; Bruker CT; Kestler DP; Foster JS; Gray KD; Solomon A; Bell JL
Am Surg; 2009 Sep; 75(9):769-75; discussion 775. PubMed ID: 19774947
[TBL] [Abstract][Full Text] [Related]
44. Formin-like2 regulates Rho/ROCK pathway to promote actin assembly and cell invasion of colorectal cancer.
Zeng Y; Xie H; Qiao Y; Wang J; Zhu X; He G; Li Y; Ren X; Wang F; Liang L; Ding Y
Cancer Sci; 2015 Oct; 106(10):1385-93. PubMed ID: 26258642
[TBL] [Abstract][Full Text] [Related]
45. BART inhibits pancreatic cancer cell invasion by inhibiting ARL2-mediated RhoA inactivation.
Taniuchi K; Iwasaki S; Saibara T
Int J Oncol; 2011 Nov; 39(5):1243-52. PubMed ID: 21833473
[TBL] [Abstract][Full Text] [Related]
46. Molecular mechanism of the anti-cancer activity of cerivastatin, an inhibitor of HMG-CoA reductase, on aggressive human breast cancer cells.
Denoyelle C; Albanese P; Uzan G; Hong L; Vannier JP; Soria J; Soria C
Cell Signal; 2003 Mar; 15(3):327-38. PubMed ID: 12531431
[TBL] [Abstract][Full Text] [Related]
47. Flavone inhibits migration through DLC1/RhoA pathway by decreasing ROS generation in breast cancer cells.
Zhu W; Ma L; Yang B; Zheng Z; Chai R; Liu T; Liu Z; Song T; Li F; Li G
In Vitro Cell Dev Biol Anim; 2016 May; 52(5):589-97. PubMed ID: 26935193
[TBL] [Abstract][Full Text] [Related]
48. KiSS1 suppresses TNFalpha-induced breast cancer cell invasion via an inhibition of RhoA-mediated NF-kappaB activation.
Cho SG; Li D; Stafford LJ; Luo J; Rodriguez-Villanueva M; Wang Y; Liu M
J Cell Biochem; 2009 Aug; 107(6):1139-49. PubMed ID: 19533666
[TBL] [Abstract][Full Text] [Related]
49. The cyclohexene derivative MC-3129 exhibits antileukemic activity via RhoA/ROCK1/PTEN/PI3K/Akt pathway-mediated mitochondrial translocation of cofilin.
Zheng Y; Ouyang Q; Fu R; Liu L; Zhang H; Hu X; Liu Y; Chen Y; Gao N
Cell Death Dis; 2018 May; 9(6):656. PubMed ID: 29844397
[TBL] [Abstract][Full Text] [Related]
50. Restoration of Arpin suppresses aggressive phenotype of breast cancer cells.
Li Y; Qiu J; Pang T; Guo Z; Su Y; Zeng Q; Zhang X
Biomed Pharmacother; 2017 Aug; 92():116-121. PubMed ID: 28531800
[TBL] [Abstract][Full Text] [Related]
51. Terrein inhibits migration of human breast cancer cells via inhibition of the Rho and Rac signaling pathways.
Kasorn A; Loison F; Kangsamaksin T; Jongrungruangchok S; Ponglikitmongkol M
Oncol Rep; 2018 Mar; 39(3):1378-1386. PubMed ID: 29328460
[TBL] [Abstract][Full Text] [Related]
52. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients.
Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F
Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190
[TBL] [Abstract][Full Text] [Related]
53. Cucurbitacin B inhibits the migration and invasion of breast cancer cells by altering the biomechanical properties of cells.
Liang J; Zhang XL; Yuan JW; Zhang HR; Liu D; Hao J; Ji W; Wu XZ; Chen D
Phytother Res; 2019 Mar; 33(3):618-630. PubMed ID: 30548720
[TBL] [Abstract][Full Text] [Related]
54. ODAM promotes junctional epithelium-related gene expression via activation of WNT1 signaling pathway in an ameloblast-like cell line ALC.
Song D; Yang S; Tan T; Wang R; Ma Z; Wang Y; Wang L
J Periodontal Res; 2021 Jun; 56(3):482-491. PubMed ID: 33452817
[TBL] [Abstract][Full Text] [Related]
55. Ras homolog gene family, member A promotes p53 degradation and vascular endothelial growth factor-dependent angiogenesis through an interaction with murine double minute 2 under hypoxic conditions.
Ma J; Xue Y; Cui W; Li Y; Zhao Q; Ye W; Zheng J; Cheng Y; Ma Y; Li S; Han T; Miao L; Yao L; Zhang J; Liu W
Cancer; 2012 Sep; 118(17):4105-16. PubMed ID: 22907703
[TBL] [Abstract][Full Text] [Related]
56. Therapeutic IMC-C225 antibody inhibits breast cancer cell invasiveness via Vav2-dependent activation of RhoA GTPase.
Molli PR; Adam L; Kumar R
Clin Cancer Res; 2008 Oct; 14(19):6161-70. PubMed ID: 18829495
[TBL] [Abstract][Full Text] [Related]
57. Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells.
Lee WJ; Chen WK; Wang CJ; Lin WL; Tseng TH
Toxicol Appl Pharmacol; 2008 Jan; 226(2):178-91. PubMed ID: 17961621
[TBL] [Abstract][Full Text] [Related]
58. ARHGAP18 Downregulation by miR-200b Suppresses Metastasis of Triple-Negative Breast Cancer by Enhancing Activation of RhoA.
Humphries B; Wang Z; Li Y; Jhan JR; Jiang Y; Yang C
Cancer Res; 2017 Aug; 77(15):4051-4064. PubMed ID: 28619708
[TBL] [Abstract][Full Text] [Related]
59. Downregulation of Notch1 inhibits the invasion and metastasis of human gastric cancer cells SGC7901 and MKN74 in vitro through PTEN activation and dephosphorylation of Akt and FAK.
Zhang XS; Hu YH; Gao HY; Lan XW; Xue YW
Mol Med Rep; 2017 Aug; 16(2):2318-2324. PubMed ID: 28627671
[TBL] [Abstract][Full Text] [Related]
60. Diaphanous-related formin-3 overexpression inhibits the migration and invasion of triple-negative breast cancer by inhibiting RhoA-GTP expression.
Jiang J
Biomed Pharmacother; 2017 Oct; 94():439-445. PubMed ID: 28779705
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
